Cart
sales@molnova.com
D-Saccharic acid 1,4-lactone hydrate
CAS No. 61278-30-6
D-Saccharic acid 1,4-lactone hydrate( —— )
Catalog No. M28363 CAS No. 61278-30-6
D-Saccharic acid 1,4-lactone hydrate is a potent β-glucuronidase inhibitor (IC50=48.4 μM). D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 53 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD-Saccharic acid 1,4-lactone hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionD-Saccharic acid 1,4-lactone hydrate is a potent β-glucuronidase inhibitor (IC50=48.4 μM). D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties.
-
DescriptionD-Saccharic acid 1,4-lactone hydrate is a potent β-glucuronidase inhibitor (IC50=48.4 μM). D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorEphB4|c-Src
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number61278-30-6
-
Formula Weight210.138
-
Molecular FormulaC6H10O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 100 mg/mL (475.87 mM))
-
SMILESO.O[C@@H]([C@H]1OC(=O)[C@H](O)[C@H]1O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bardelle C, et al. Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors. Bioorg Med Chem Lett. 2010;20(21):6242-6245.
molnova catalog
related products
-
NVP-DKY709
NVP-DKY709 is a potent IKZF2 inhibitor for the treatment of cancers.
-
MBC-11
MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC), with potential to treat tumor-induced bone disease (TIBD).
-
Somatostatin Acetate
Somatostatin (GHIH), a peptide hormone, regulates the endocrine system and affects neural transmission and cell proliferation by interacting with G-protein-coupled somatostatin receptors and inhibiting the release of multiple secondary hormones. Somatostatin inhibits secretion of insulin and glucagon.
